Extraintestinal manifestations at baseline, and the effect of tofacitinib, in patients with moderate to severe ulcerative colitis

by David T. Rubin, Walter Reinisch, Thomas Greuter, Paulo G. Kotze, Marcia Pinheiro, Rajiv Mundayat, Eric Maller, Marc Fellmann, Nervin Lawendy, Irene Modesto, Stephan R. Vavricka, Gary R. Lichtenstein
Published 2021-05-01

Biosimilar knowledge and viewpoints among Brazilian inflammatory bowel disease patients

by Karoline Soares Garcia, Bianca Pocopetz Facas, Marta Brenner Machado, Fábio Vieira Teixeira, Luisa Avedano, Sanna Lönnfors, Rogério Saad Hossne, Laurent Peyrin-Biroulet, Natália Sousa Freitas Queiroz
Published 2021-05-01

The safety of drugs for inflammatory bowel disease during pregnancy and breastfeeding: the DUMBO registry study protocol of GETECCU

by María Chaparro, María G. Donday, Francisco Abad-Santos, Francisco Javier Martín de Carpi, Miguel Ángel Maciá-Martínez, Dolores Montero, Diana Acosta, Yanire Brenes, Javier P. Gisbert
Published 2021-06-01

Experience with regorafenib in the treatment of hepatocellular carcinoma

by Alessandro Granito, Antonella Forgione, Sara Marinelli, Matteo Renzulli, Luca Ielasi, Vito Sansone, Francesca Benevento, Fabio Piscaglia, Francesco Tovoli
Published 2021-05-01

The contribution of bile acid metabolism to the pathogenesis of infection

by Benjamin H. Mullish, Jessica R. Allegretti
Published 2021-05-01

Critical roles of bile acids in regulating intestinal mucosal immune responses

by Ruicong Sun, Chunjin Xu, Baisui Feng, Xiang Gao, Zhanju Liu
Published 2021-05-01

Novel risk factors and outcomes in inflammatory bowel disease patients with infection

by Elida Voth, Dipesh Solanky, Edward V. Loftus, Darrell S. Pardi, Sahil Khanna
Published 2021-03-01

Model-based effectiveness and cost-effectiveness of risk-based selection strategies for adjuvant chemotherapy in Dutch stage II colon cancer patients

by Gabrielle Jongeneel, Marjolein J. E. Greuter, Felice N. van Erning, Miriam Koopman, Geraldine R. Vink, Cornelis J. A. Punt, Veerle M. H. Coupé
Published 2021-03-01

Immune response against and translation to therapy

by Kanika Sehgal, Sahil Khanna
Published 2021-05-01

Colorectal cancer screening programme: is the French faecal immunological test (FIT) threshold optimal?

by Anna Pellat, Jacques Deyra, Marie Husson, Robert Benamouzig, Romain Coriat, Stanislas Chaussade
Published 2021-05-01

Evolution of clinical guidelines for antimicrobial management of infection

by Abdelkader Chaar, Paul Feuerstadt
Published 2021-05-01

Head-to-head comparison of biological drugs for inflammatory bowel disease: from randomized controlled trials to real-world experience

by Fabio Salvatore Macaluso, Marcello Maida, Mauro Grova, Federica Crispino, Giulia Teresi, Adele Orlando, Ambrogio Orlando
Published 2021-05-01

Anti-tumor necrosis factor-induced lupus in patients with inflammatory bowel disease: a hospital-based cohort study from Korea

by Su Jin Choi, Soo Min Ahn, Ji Seon Oh, Seokchan Hong, Chang-Keun Lee, Bin Yoo, Byong Duk Ye, Suk-Kyun Yang, Sang Hyoung Park, Yong-Gil Kim
Published 2021-03-01